tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market
Advertisement

Oncolys BioPharma, Inc. (4588) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

4588 Financial Forecast

4588 Earnings Forecast

The previous quarter’s earnings for 4588 were -¥32.66.
The previous quarter’s earnings for 4588 were -¥32.66.

4588 Sales Forecast

The previous quarter’s earnings for 4588 were ¥0.00.
The previous quarter’s earnings for 4588 were ¥0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:4588
TipRanks AITipRanks
Not Ranked
TipRanks
¥613
Hold
-0.97%
Downside
Reiterated
07/24/25
Oncolys BioPharma, Inc.'s stock score is primarily impacted by its weak financial performance, with persistent losses and negative cash flows posing significant risks. The technical analysis indicates some short-term bullish potential, but this is overshadowed by poor valuation metrics, including a negative P/E ratio. Investors should be cautious given the company's current financial instability.
AI Firm
¥584
Hold
-5.65%
Downside
Upgraded
05/30/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:4588
TipRanks AITipRanks
Not Ranked
TipRanks
¥613
Hold
-0.97%
Downside
Reiterated
07/24/25
Oncolys BioPharma, Inc.'s stock score is primarily impacted by its weak financial performance, with persistent losses and negative cash flows posing significant risks. The technical analysis indicates some short-term bullish potential, but this is overshadowed by poor valuation metrics, including a negative P/E ratio. Investors should be cautious given the company's current financial instability.
AI Firm
¥584
Hold
-5.65%
Downside
Upgraded
05/30/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

4588 Analyst Recommendation Trends

Rating
May 25
Jul 25
Strong Buy
0
0
Buy
0
0
Hold
1
5
Sell
0
0
Strong Sell
0
0
total
1
5
In the current month, 4588 has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 4588 average Analyst price target in the past 3 months is 584.00.
Each month's total comprises the sum of three months' worth of ratings.

4588 Stock Forecast FAQ

What is JP:4588’s average 12-month price target, according to analysts?
Based on analyst ratings, Oncolys BioPharma, Inc.’s 12-month average price target is 584.00.
    What is JP:4588’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for JP:4588, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Oncolys BioPharma, Inc. a Buy, Sell or Hold?
        Oncolys BioPharma, Inc. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Oncolys BioPharma, Inc.’s share price target?
          The average share price target for Oncolys BioPharma, Inc. is 584.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is ¥584.00 ,and the lowest forecast is ¥584.00. The average share price target represents -5.65% Decrease from the current price of ¥619.
            What do analysts say about Oncolys BioPharma, Inc.?
            Oncolys BioPharma, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Oncolys BioPharma, Inc.?
              To buy shares of JP:4588, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis